SF 3087 Minnesota Senate · 2025-2026 Regular Session

Restrictions placed on the sale of certain over-the-counter allergy medications modifications

This bill amends Minnesota law to restrict sales of over-the-counter allergy medications containing ephedrine or pseudoephedrine (common in products like Sudafed). It limits single sales to two packages or six grams total base weight, requires sales behind counters by licensed staff, and mandates ID checks and written sales logs for buyers. Buyers under 18 are prohibited from purchasing these products, and total monthly purchases are capped at 6.7 grams. These rules apply directly to pharmacies and retail stores selling such allergy medications.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 27, 2025 Last action Mar 27, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 27, 2025
Committee
Referred to Health and Human Services
upper
Mar 27, 2025
Introduced
Introduction and first reading
upper
1 primary · 1 co-sponsor

Sponsors